AstraZeneca's new asthma drug to take on GSK, Teva and Novartis after clearing clinical hurdles
Teva sues Cipla over generic asthma inhalers
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development
Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma
Teva's Respiratory Drugs Contribute 11% to Specialty Medicines
Teva's DuoResp Spiromax wins silver at MDEA
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App